Article Details
Retrieved on: 2025-04-25 20:30:19
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Investors who purchased stock in Zenas BioPharma, Inc. (NASDAQ: ZBIO) September 2024 IPO and lost money should call Cohen Milstein to join a class ...
Article found on: www.globenewswire.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here